Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits

Journal of Veterinary Medicine, Series B

Volumn 49, Issue 10, 2002, Pages 507-512

  Elmas, M ^a   Yazar, E ^a   Bas A L ^a   Tras B ^a   Bayezit, M ^a,b   Yapar, K ^a,b  

^a SELCUK UNIVERSITY   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; DRUG CARRIER; ENROFLOXACIN; LIPOSOME; QUINOLONE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; RABBIT; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DRUG CARRIERS; FLUOROQUINOLONES; INJECTIONS, INTRAMUSCULAR; LIPOSOMES; QUINOLONES; RABBITS; TISSUE DISTRIBUTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036942528     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0450.2002.00603.x     Document Type: Article

References (39)

1. Anadon, A., M. R. Martinez-Larranaga, M. J. Diaz, P. Bringas, M. A. Martinez, and M. L. Fernandez-Cruz, 1995: Pharmacokinetics and residues of enrofloxacin in chickens. Am. J. Vet. Res. 56, 501-505.
2. Anadon, A., M. R. Martinez-Larranaga, M. J. Diaz, M. L. Fernandez-Cruz, M. A. Martinez, M. T. Frejo, M. Martinez, J. Iturbe,. and M. Tafur, 1999: Pharmacokinetics variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. Am. J. Vet. Res. 60, 1377-1382.
3. Baş, A.L., M. Elmas, A. şimşek, B. Traş, E. Yazar and H. H. Hadimli, 2000: Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish shepherd dog neutrophis in vitro. Rev. Med. Vet. 151, 415-420.
4. Bauditz, R., 1989: Results of clinical studies with Baytril in dogs and cats. Vet. Med. Rev. 2, 137-140.
5. Bermudez, L. E., 1994: Use of liposome preparation to treat mycobacterial infections. Immunobiol. 4, 578-583.
6. Broome, R. C., D. L. Brooks, J. G. Babish, D. D. Copeland and G. M. Conzelman, 1991: Pharmacokinetics properties of enrofloxacin in rabbits. Am. J. Vet. Res. 52, 1835-1841.
7. Cabanes, A., M. Arboix, J. M. Garcia-Anton and F. Reig, 1992: Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am. J. Vet. Res. 53, 2090-2093.
8. Cabanes, A., F. Reig, J. M. Garcia-Anton and M. Arboix, 1995: Sustained release of liposome encapsulated enrofloxacin after intramuscular administration in rabbits. Am. J. Vet. Res. 56, 1498-1501.
9. Cabanes, A., F. Reig, J. M. Garcia-Anton and M. Arboix, 1998: Evaluation of free and liposome-encapsulated gentamicin for intramuscular sustained release in rabbits. Res. Vet. Sci. 64, 213-217.
10. Cester, C. C. and P. L. Toutain, 1997. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. J. Pharm. Sci. 86, 1148-1155.
11. Düzgüneş, N., D. L. Flasher, M. V. Reddy, J. Luna-Herrera and P. R. J. Gangadharam, 1996: Treatment of mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. Antimicrob. Agents Chemother. 40, 2618-2621.
12. Elmas, M., E. Yazar, B. Traş, A. L. Baş and A. Eryavuz, 2000: Pharmacokinetics and oral bioavailability of enrofloxacin in faunated and defaunated Angora goats. Revue Med. Vet. 151, 507-510.
13. Elmas, M., B. Traş, S. Kaya, A.L. Baş, E. Yazar and E. Yarsan, 2001: Pharmacokinetics of enrofloxacin after single intravenous and intramuscular administration in angora goats. Can. J. Vet. Res. 65, 64-67.
14. Fielding R. M., L. Moon-McDermott and R.O. Lewis, 1999: Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration. J. Drug Target. 6, 415-426
15. Fraile, L. J., C. Martinez, J. J. Aramayona, A. R. Abadia, M. A. Bregante and Garcia, 1997: Limited capacity of neonatal rabbits to eliminate enrofloxacin and ciprofloxacin. Vet. Q. 1, 162-167.
16. Herman, E. H., A. Rahman and V. J. Ferrans, 1983: Prevention of chronic doxorubicin cardiotoxicity in Beagles by liposomal encapsulation. Cancer Res. 43, 5427-5432.
17. Intorre, L., G. Mengozzi, M. Bertini, M. Bagliacca, E. Luchetti and G. Soldani, 1997: The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in muscowy duck. Vet. Res. Commun. 21, 127-136.
18. Kaartinen, L., M. Salonen, L. Alli and S. Pyorala, 1995: Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J. Vet. Pharmacol. Therap. 18, 357-162.
19. Kadir, F., W. M. C. Eling and D. J. A. Crommelin, 1992: Kinetics and prophylactic efficacy of increasing dose of liposome-encapsulated chloroquineafter IM injection. J. Control. Release 20, 47-54.
20. Kim C. K. and J. H. Han, 1995: Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsul. 12, 437-446
21. Küng, K., J. L. Riond and M. Wanner, 1993: Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Therap. 16, 462-468.
22. Lopez-Berestein, G., G. P. Bodey and V. Fainstein, 1989: Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Inter. Med. 149, 2533-2536.
23. Majumdar, S., D. Flasher, D. S. Friend and P. Nassos, 1992: Efficacies of liposome encapsulated streptomycin and ciprofloxacin against M. avium - M. intracellulare complex infections in human peripheral blood monocytes/macrophages. Antimicrob. Agents Chemother. 36, 2808-2815.
24. McKellar, Q., 1996: Clinical relevance of the pharmacologic properties of fluoroqinolones. Compend. Contin. Educ. Pract. Vet. Suppl. 18, 14-20.
25. McKellar, Q., I. Gibson, A. Monteiro and M. Bregante, 1999: Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrob. Agents Chemother. 43, 1988-1992.
26. Mengozzi, G., L. Intorre, S. Bertini and M. D. Soldani, 1996: Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am. J. Vet. Res. 57, 1040-1043.
27. Ohsawa, T., Y. Matsukawa, Y. Takakura, M. Hashida and H. Sezaki, 1985: Fate of lipid and encapsulated drug after intramuscular administration of liposomes prepared by the freeze-thawing method in rats. Chem. Pharm. Bull. 33, 357-377.
28. Orsini, J. A. and S. Perkons, 1992: The fluoroquinolones: clinical applications in veterinary medicine. Compendium Small Anim. 9, 1491-1495.
29. Sallovitz J. M., M. I. Zonco Menghini and C. E. Lanusse, 1998: Impact of liposomes as delivery systems in veterinary medicine. Vet. Res. 29, 409-430.
30. Scheer, M., 1987a: Studies on antimicrobial activity of Baytril. Vet. Med. Rev. 2, 90-99.
31. Scheer, M., 1987b: Concentrations of active ingredient in serum and tissues after oral and parenteral administration of Baytril. Vet. Med. Rev. 2, 104-118.
32. Schreier, H., M. Levy and P. Mihalko, 1987: Sustained release of liposome-encapsulated gentamicin and fate of phospholipid following intramuscular injection in mice. J. Control. Release 5, 187-92.
33. Shumaker, R. C., 1986: PKCALC: A Basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabol. Rev. 17, 331-348.
34. Titulaer, H. A., W. M. Eling, D. J. Crommelin, P. A. Peeters and J. Zuidema, 1990: The parenteral controlled release of liposome encapsulated chloroquine in mice. J. Pharm. Pharmacol. 42, 529-532.
35. Tyczkowska, K., K. M. Hedeen, D. P. Aucoin and A. Aronson, 1989: High performance liquid chromatographic for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J. Chromatogr. 493, 337-346.
36. Valladares, J. E., J. Freixas, J. Alberola, C. Franquelo, C. Cristofol and M. Arboix, 1997: Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am. J. Trop. Med. Hyg. 57, 403-406.
37. Vancutsem, P. M., J. G. Babish and W. S. Schwark, 1990: The flouroquinolone antimicnobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet. 80, 173-186.
38. Wagner J. G., 1975: Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Pub. Inc., Hamilton, IL.
39. Walker, R. D., G. E. Stein, J. G. Hauptman and K. H. McDonald, 1992: Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am. J. Vet. Res. 53, 2315-2319.